Gilead Sciences (GILD) Asset Utilization Ratio (2009 - 2026)
Gilead Sciences' (GILD) Asset Utilization Ratio was 0.62 for Q3 2026, up 20.8% from 0.51 a year earlier and up 6.7% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Gilead Sciences was 0.50, up 5.1% from FY2024.
- Asset Utilization Ratio has increased for seven consecutive years.
- By year, Asset Utilization Ratio came in at 0.47 in FY2024 (+9.7%), 0.43 in FY2023 (+4.0%), 0.42 in FY2022 (+3.9%) and 0.40 in FY2021 (+5.5%).
- The Q3 2026 figure ranks as the highest quarterly Asset Utilization Ratio since Q2 2016.
- Year over year, Asset Utilization Ratio has now increased in each of the last three quarters, with growth averaging 7.2% over the last eight quarters.
- The high point for year-over-year Asset Utilization Ratio in five years was Q3 2026 (growth of 20.8%); the low point was Q3 2025 (a decline of 2.7%).
- Per Business Quant data, the three quarters before Q3 2026 came in at 0.58 (Q2 2026), 0.52 (Q1 2026) and 0.50 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 0.43 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.62 |
| Jun 30, 2026 | 0.58 |
| Mar 31, 2026 | 0.52 |
| Dec 31, 2025 | 0.50 |
| Sep 30, 2025 | 0.51 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | 0.50 |
| Dec 31, 2024 | 0.51 |
| Sep 30, 2024 | 0.52 |
| Jun 30, 2024 | 0.51 |
| Mar 31, 2024 | 0.46 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.44 |
| Jun 30, 2023 | 0.44 |
| Mar 31, 2023 | 0.43 |
| Dec 31, 2022 | 0.43 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.44 |
| Mar 31, 2022 | 0.42 |
| Dec 31, 2021 | 0.40 |
API Access
Gilead Sciences Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();